HEALTH OF WOMAN. 2016.8(114):25–28; doi 10.15574/HW.2016.114.10 
 

Early predictors of placental dysfunction 
 

Melnik J. M., Shlyahtina A. A.

Kiev city center of reproductive and perinatal medicine

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev

The article presents the predictors of placental dysfunction on the early stage of pregnancy.

The objective: the search for prognostic markers and criteria for the occurrence of placental insufficiency in the early stages of the gestational process to optimize the pregnancy and labor with improved perinatal outcomes.

Patients and methods. To solve this goal in the period from 2013 to 2015 were conducted a comprehensive survey of 334 pregnant women, which depending on the peculiarities of pregnancy and childbirth were divided into groups. The control group consisted of 236 pregnant women with uncomplicated gestational period, no morphological signs of placental dysfunction. The study group included 98 patients with a complicated pregnancy who had revealed violations of the fetal-placental relations, which was confirmed by morphological examination of the placenta in the postpartum period.

Results. It was found that pregnant women with placental insufficiency in the first trimester of pregnancy have higher levels of interleukin-1B (IL-1v) and interleukin-3 (IL-3) in comparison with physiological pregnancy, as well as there is a direct significant correlation between IL-1v and pulsative index (PI) in the spiral (r=0.84) and uterine artery (r=0.77), and the inverse correlation between the level of IL-3 and PI in the terminal branches of the umbilical artery (r=-0.69). Verified an inverse relationship between the concentration of endothelin-1, the level of vascular endothelial growth factor (r=-0.87) and placental growth factor (r=-0.73), and also a direct link between the content of endothelin-1 and PI in spiral arteries (r=0.89), uterine artery (r=0.83) and the terminal branches of the umbilical artery (r=0.79).

Conclusion. Thus, it is proven that early predictors of placental dysfunction can be considered the concentration of endothelin-1, vascular endothelial growth factor, placental growth factor, interleukin-1, interleukin-3, and the indices of pulsative index.

Key words: placental dysfunction, predictors, endothelin-1, vascular endothelial growth factor, placental growth factor, interleukin, pulsative index.

REFERENCES

1. Pogorelova TN, Gunko VO, Linde VA. 2014. Proteomnyiy disbalans v platsente pri ee nedostatochnosti. Ros. Vest. Akush. Ginek. 14;2:9–13.

2. Murthi P, Brouillet S, Pratt A et al. 2015. An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction. Mol. Med. 21;1:645–656. https://doi.org/10.2119/molmed.2015.00071; PMid:26208047 PMCid:PMC4749495

3. Triunfo S, Crovetto F, Crispi F et al. 2016. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia. Placenta. 42:44–50. https://doi.org/10.1016/j.placenta.2016.04.005; PMid:27238713

4. Bouzid A, Ayachi A, Dhaoudi H et al. 2016. Relevance of first trimester serum markers to predict pregnancy complications: A Tunisian preliminary study. Gynecol. Obstet. Fertil. 44;2:96–100. https://doi.org/10.1016/j.gyobfe.2016.01.002; PMid:26857043

5. Triunfo S, Crovetto F, Rodriguez-Sureda V et al. 2016. Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering small-for-gestational age neonates. Ultrasound. Obstet. Gynecol. – http://onlinelibrary.wiley.com/doi/10.1002/uog.15978/abstract

6. Christians JK, Beristain AG. 2016. ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts. Cell. Adh. Migr. 10;1–2:147–153.

7. O’Gorman N, Wright D, Syngelaki A et al. 2016. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am. J. Obstet. Gynecol. 214;1:103–112. https://doi.org/10.1016/j.ajog.2015.08.034

8. Tsiakkas A, Saiid Y, Wright A et al. 2016. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation. Am. J. Obstet. Gynecol. 215;1:87.

9. Crovetto F, Triunfo S, Crispi F et al. 2016. First trimester screening with specific algorithms for early and late onset fetal growth restriction. Ultrasound. Obstet. Gynecol. – http: //onlinelibrary. wiley.com/doi/10.1002/uog.15879/abstract;jsessionid=1E067EED03F87534358072E4615D233A.f04t02

10. Komacki J, Skrzypczak J. 2015. The use of Doppler in the second half of pregnancy. Ginekol. Pol. 86;8:626–630. https://doi.org/10.17772/gp/57867; PMid:26492713

11. Kroener L, Wang ET, Pisarska MD. 2016. Predisposing Factors to Abnormal First Trimester Placentation and the Impact on Fetal Outcomes. Semin. Reprod. Med. 34;1:27–35. https://doi.org/10.1055/s-0035-1570029; PMid:26696276

12. Lecarpentier E, Tsatsaris V. 2016. Angiogenic balance (sFlt-1/PlGF) and preeclampsia. Ann. Endocrinol. 77;2:97–100. https://doi.org/10.1016/j.ando.2016.04.007; PMid:27130072

13. Tong M, Kleffmann T, Pradhan S et al. 2016. Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication. Hum. Reprod. 31;4:687–699. https://doi.org/10.1093/humrep/dew004; PMid:26839151

14. Rodriguez A, Tuuli MG, Odibo AO. 2016. First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction. Clin. Lab. Med. 36;2:331–351. https://doi.org/10.1016/j.cll.2016.01.007; PMid:27235916

15. Van den Bosch T, Van Schoubroeck D, Timmerman D. 2015. Maximum Peak Systolic Velocity and Management of Highly Vascularized Retained Products of Conception. J Ultrasound. Med. 34;9:1577–1582. https://doi.org/10.7863/ultra.15.14.10050; PMid:26254150

16. Zhong Y, Zhu F, Ding Y. 2015. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth. 15:191. https://doi.org/10.1186/s12884-015-0608-y; PMid:26303460 PMCid:PMC4548561